Metabolomics: Market Research Report

Date: January 11, 2014
Pages: 191
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M47479ADB59EN
Leaflet:

Download PDF Leaflet

Metabolomics: Market Research Report
This report analyzes the worldwide markets for Metabolomics in US$ Million by the following Product Segments: Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 34 companies including many key and niche players such as -
  • AB SCIEX
  • Agilent Technologies, Inc.
  • Biocrates Life Sciences AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Metabolomics

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Metabolomics – The Current Spotlight of 'Omics' Toolbox
Growth Drivers
Market Barriers & Challenges
Metabolomics: A Regional Perspective
US and Europe Spearhead the Global Metabolomics Market
Asia-Pacific: The Fastest Growing Metabolomics Market
Biotechnology and Pharmaceutical Sectors Drive Metabolomics Research
Demand for Data Analysis Tools and Software on Rise
Bioinformatics-based Metabolomics Applications Poised to Grow
List of Select Metabolomic Analysis Software
Metabolomics Laboratory Management Systems (LIMS): Growing in Significance
Synopsis of Select Metabolomic Databases
Some Examples of Metabolomics LIMS
Targeted Metabolomics in Newborn Screening: An Area of Success
Lack of Standardization - A Prime Concern
Competitive Scenario

2. AN INSIGHT INTO METABOLOMICS APPLICATIONS

Metabolomics Gain Rapid Foothold in Drug Discovery and Toxicology Testing
Metabolomic Research - A Prospective Tool to Validate Potential Targets
Metabolite Profiling for Biomarker Discovery Gaining Prominence

Table 1. Global Biomarkers Market by Discovery Technology (2013): Percentage Share Breakdown for Bioinformatics, Imaging Technologies and Omics Technologies (includes corresponding Graph/Chart)

Oncology – A Key Focus Area for Metabolomics-Based Biomarker Discovery

Table 2. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 3. New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart)
Table 4. World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)

Role of Metabolomics in Personalized Medicine

Table 5. Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
Table 6. %Growth of 65+ Population in North America, Europe, Asia, and Latin America (includes corresponding Graph/Chart)

Food & Nutrition Looks Up to Metabolomics
Metabolomic Profiling in Food Safety Testing: An Opportunity to Tap
Global Food Safety Concerns: A Review
Biotechnology and Bioinformatics - The Backbone of New Testing Technologies
Plants and Agriculture: Metabolomics to Play a Vital Role
Metabolites Present in Select Agricultural Crops
Metabolomics Research on Tomato and Potato Crops
Metabolomics for Environmental Sciences
Nutrigenomics to Benefit from Metabolomics Approach

3. AN INSIGHT INTO SELECT SEPARATION AND DETECTION TECHNOLOGIES

A Primer…
Separation and Detection Techniques: A Review
Separation Techniques
Gas chromatography (GC)
Capillary Electrophoresis (CE)
High Performance Liquid Chromatography (HPLC)
Ultra Performance Liquid Chromatography (UPLC)
Detection Techniques
Mass spectrometry (MS)
Nuclear Magnetic Resonance (NMR) Spectroscopy (NMR)
Surface-based Mass Analysis
Common and Prospective Technologies in Metabolite Profiling
Noteworthy Trends
High Performance Liquid Chromatography (HPLC) Dominates the Market
Major Trends in Gas Chromatography: A Quick Review
Advances in GC Technology
Hyphenated Technologies: Order of the Day
Liquid Chromatography Gains Space in Metabolomics Analysis
MS Systems with UHPLC: A Novel Fusion
HILIC Systems Soaring in Popularity
Capillary Electrophoresis Gains Prominence

4. PRODUCT OVERVIEW

Metabolomics - Introduction
Metabolome
Metabolites
Metabolomics Evolution over the Years
Metabolomics Vs. Metabonomics
Analytical Methods
Key Application Areas
Toxicity Assessment/Toxicology
Functional Genomics
Nutrigenomics
Conceptual Approaches in Metabolomics
Target Analysis
Metabolite Profiling
Metabolomics
Metabolic Fingerprinting
Technological Advancements in Metabolomics
Metabolomics as Systems Biology Tool
Metabolomics: A Link between Genetics and Ecology
Limitations
An Overview of Metabolomics Research
Adoption of Metabolomics Research by Type of Entity
Implementation of Metabolomics Research by Nature of Study
Implementation of Metabolomics Research by Type of Laboratory
Key Issues Associated with Metabolomics Study

5. PRODUCT INTRODUCTIONS/INNOVATIONS

BIOCRATES Life Sciences Introduces Metabolomics-based Bile Acids Kit
Waters Corporation Releases New Data Analysis Software Packages for Proteomics and Metabolomics/Lipidomics Analyses
Researchers Demonstrates Biocrates’ AbsoluteIDQ p180 Metabolomics Test Kit to Predict Alzheimer’s Disease
Metabolon Introduces Quantose IR Prediabetes Test
Metabolon Rolls Out Fourth Generation DiscoveryHD4 Metabolomics Platform
Bruker Introduces Next-Generation GC-APCI II GC-MS Interface with Automatic MS Calibration
Bruker Introduces MS-based Solutions and Systems
Metabolon Announces Expansion of Biochemical Profiling Capabilities
Health Diagnostic Laboratory Introduces Quantose-based New Diabetes Prevention & Management Panel
Bruker Launches COMPACT LC-QqTOF Mass Spectrometer
BIOCRATES to Introduce Thermo Edition of AbsoluteIDQ® p150
Shimadzu Introduces GC/MS Metabolite Database Ver. 2
Shimadzu Releases New LC/MS/MS Method Package for Primary Metabolites
BIOCRATES Life Sciences to Introduce Waters Xevo® TQ MS Editions for AbsoluteIDQ® p180 und p150

6. RECENT INDUSTRY ACTIVITY

Metabolon Collaborates with Metdia Biotech
Metabolon and Baylor College of Medicine Collaborate to Launch Global MAPS for Inborn Errors of Metabolism
Metabolomic Diagnostic Secures €750,000 Seed Investment
Metabolon Enters into Collaboration with GlaxoSmithKline
Metabolomic Discoveries Enters into Distributorship Agreement with Filgen
Metabolon Inks Collaboration Agreement with Human Longevity
Metabolon Collaborates with the Carlos Slim Institute, Clinica Ruiz and Patia
Global Genomics Group to Partner with Metabolon
Human Metabolome Technologies Secures Patent for Method of Measuring Ethanolamine Phosphate
Metabolon and Bostwick Laboratories Enter into Marketing Agreement
IMDEA Food Collaborates with Metabolon to Advance Nutrition-based Personalized Medicine
University of Alberta, BGI Shenzhen and MTI Collaborate to Commercialize PolypDx Metabolomic-based Diagnostic Test
Agilent Technologies Collaborates with DGIST on Neurometabolomics Research
DHMRI Enters into Strategic Alliance with Metabolon
AB SCIEX, Genedata, and LECO Enter into Technology Partnership
Matrix-Bio Enters into Metabolomics Biomarker Licensing Agreement with Quest
Chenomx Collaborates with Spain’s Centre for Omic Sciences
Agilent Collaborates with Spain's Centre for Omic Sciences
Metabolon Renews Multi-Year Agreement with Syngenta
Human Metabolome Technologies Inaugurates New Office in the US
LECO Enters into Agreement with DOE's Lawrence Berkeley National Laboratory
Metabolon Acquires Lipomics Technologies
Takeda and Metabolon Enter into Long-Term Research Alliance
Biocrates Enters into Distribution and Co-Marketing Agreement with MATERLAB and ONKOGEN Diagnostik
Waters and Nonlinear Dynamics Enter into Agreement to Co-Develop New Analytical Solution

7. FOCUS ON SELECT PLAYERS

AB SCIEX (US)

Agilent Technologies, Inc. (US)
Biocrates Life Sciences AG (Austria)
Bio-Rad Laboratories, Inc. (US)
Bruker Corporation (US)
Chenomx, Inc. (Canada)
Human Metabolome Technologies, Inc. (Japan)
LECO Corporation (US)
Metabolon, Inc. (US)
Metanomics GmbH (Germany)
Shimadzu Corporation (Japan)
SiDMAP, LLC (US)
Thermo Fisher Scientific, Inc. (US)
Life Technologies Corp. (US)
Waters Corporation (US)

8. GLOBAL MARKET PERSPECTIVE

Table 7. World Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 8. World Historic Review for Metabolomics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)
Table 9. World 13-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 2008, 2014 and 2020 (includes corresponding Graph/Chart)
Table 10. World Recent Past, Current & Future Analysis for Metabolomics by Segment - Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 11. World Historic Review for Metabolomics by Segment - Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)
Table 12. World 13-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Revenues for Bioinformatics Tools in Metabolomic Research, Bioanalytical Instruments and Equipment, and Metabolomics Applications Markets for Years 2008, 2014 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Outlook
Strong Emphasis on Metabolomics Research
Personalized Medicine – An Opportunity for Metabolomics Technology
Product Introductions/Innovations
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 13. US Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 14. US Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Outlook
Chenomx, Inc. – A Key Player
B. Market Analytics

Table 15. Canadian Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 16. Canadian Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Outlook
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 17. Japanese Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 18. Japanese Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Outlook
Personalized Medicine: Opportunities for Growth

Table 19. Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)

Strategic Corporate Developments
B. Market Analytics

Table 20. European Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 21. European Historic Review for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)
Table 22. European 13-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Dollar Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2008, 2014 and 2020 (includes corresponding Graph/Chart)

4A. FRANCE

Market Analysis

Table 23. French Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 24. French Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Outlook
Metanomics GmbH – A Key Player
B. Market Analytics

Table 25. German Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 26. German Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4C. ITALY

Market Analysis

Table 27. Italian Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 28. Italian Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

Market Analysis

Table 29. UK Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 30. UK Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

4E. REST OF EUROPE

A. Market Analysis
Outlook
Austria
Finland
Product Introductions/Innovations
Strategic Corporate Developments
Biocrates Life Sciences AG (Austria) – A Major Player
B. Market Analytics

Table 31. Rest of Europe Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 32. Rest of Europe Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Outlook
Australia
University of Melbourne at the Forefront of Metabolomics Research
B. Market Analytics

Table 33. Asia-Pacific Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 34. Asia-Pacific Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

6. LATIN AMERICA

A. Market Analysis
Outlook
Strategic Corporate Developments
B. Market Analytics

Table 35. Latin American Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 36. Latin American Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

7. REST OF WORLD

Market Analysis

Table 37. Rest of World Recent Past, Current & Future Analysis for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 38. Rest of World Historic Review for Metabolomics Analyzed with Annual Revenue Figures in US$ Million for Years 2008 through 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 34 (including Divisions/Subsidiaries - 37)
The United States (22)
Canada (2)
Japan (4)
Europe (8)
  Germany (3)
  The United Kingdom (1)
  Spain (1)
  Rest of Europe (3)
Asia-Pacific (Excluding Japan) (1)
Skip to top


Ask Your Question

Metabolomics: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: